T Cells Targeting MAGE-A4 Shrink Tumors.
Sign Up to like & getrecommendations! Published in 2020 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-nb2020-059
Abstract: Autologous T cells engineered to target the MAGE-A4 cancer testis antigen successfully shrank a wide range of solid tumors with a manageable toxicity profile. In a phase I trial, the therapy, ADP-A2M4, showed the most… read more here.
Keywords: targeting mage; shrink tumors; mage shrink; mage ... See more keywords